biote (NASDAQ:BTMD – Get Rating) and Ascend Wellness (OTC:AAWH – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability.
Analyst Ratings
This is a breakdown of recent ratings for biote and Ascend Wellness, as reported by MarketBeat.
Get biote alerts:| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| biote | 0 | 0 | 4 | 0 | 3.00 |
| Ascend Wellness | 0 | 0 | 3 | 0 | 3.00 |
biote presently has a consensus target price of $10.25, indicating a potential upside of 138.65%. Ascend Wellness has a consensus target price of $9.00, indicating a potential upside of 542.86%. Given Ascend Wellness' higher probable upside, analysts clearly believe Ascend Wellness is more favorable than biote.
Volatility and Risk
biote has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500. Comparatively, Ascend Wellness has a beta of 2.63, meaning that its stock price is 163% more volatile than the S&P 500.Valuation & Earnings
This table compares biote and Ascend Wellness' gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| biote | N/A | N/A | $11.11 million | N/A | N/A |
| Ascend Wellness | $332.38 million | 0.79 | -$122.66 million | ($0.46) | -3.04 |
biote has higher earnings, but lower revenue than Ascend Wellness.
Profitability
This table compares biote and Ascend Wellness' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| biote | N/A | -20.05% | 5.99% |
| Ascend Wellness | -21.54% | -35.74% | -7.98% |
Institutional & Insider Ownership
3.8% of biote shares are held by institutional investors. Comparatively, 0.0% of Ascend Wellness shares are held by institutional investors. 20.0% of biote shares are held by insiders. Comparatively, 24.9% of Ascend Wellness shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Summary
biote beats Ascend Wellness on 6 of the 10 factors compared between the two stocks.
About biote
(Get Rating)
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
About Ascend Wellness
(Get Rating)
Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods. Its cannabis product categories include flowers, pre-rolls, concentrates, vapes, edibles, and other cannabis-related products. As of December 31, 2021, the company operated 20 retail locations. It also sells its products to third-party licensed cannabis retail stores. The company was incorporated in 2018 and is headquartered in New York, New York.
Receive News & Ratings for biote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for biote and related companies with MarketBeat.com's FREE daily email newsletter.